NUZ 6.25% 22.5¢ neurizon therapeutics limited

PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial, page-381

  1. 106 Posts.
    lightbulb Created with Sketch. 21
    Good to see a rise again. Hopefullly it continues on the back of edging closer to FDA approval.

    Best product in the market by far so far ....not perfect but best available nontheless.

    Managment perhaps not perfect , board changes cause instability.

    At the core is the product and its ineherent value - keep eyes on the core
 
watchlist Created with Sketch. Add NUZ (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.